A Phase I Randomized Open Label, Single Dose, 2-period Crossover Study To Evaluate Food Effect On The Pharmacokinetics Of Pf-04136309 In Healthy Volunteers.

Trial Profile

A Phase I Randomized Open Label, Single Dose, 2-period Crossover Study To Evaluate Food Effect On The Pharmacokinetics Of Pf-04136309 In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2016

At a glance

  • Drugs PF 4136309 (Primary)
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 25 May 2016 Status changed from recruiting to completed.
    • 14 Apr 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2016.
    • 14 Apr 2016 Planned primary completion date changed from 1 Apr 2016 to 1 May 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top